Insufficient scRNA-seq data for expression of PTGDR2 at single-cell level.
Insufficient scRNA-seq data for expression of PTGDR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 300.37 | 2610 / 2642 | 75% | 2.80 | 529 / 705 |
stomach | 95% | 883.40 | 341 / 359 | 50% | 1.51 | 143 / 286 |
intestine | 77% | 653.24 | 743 / 966 | 54% | 1.51 | 287 / 527 |
esophagus | 87% | 123.80 | 1252 / 1445 | 23% | 0.68 | 43 / 183 |
liver | 42% | 26.76 | 95 / 226 | 52% | 2.68 | 210 / 406 |
muscle | 90% | 135.62 | 724 / 803 | 0% | 0 | 0 / 0 |
pancreas | 42% | 28.09 | 137 / 328 | 48% | 2.07 | 85 / 178 |
bladder | 62% | 66.67 | 13 / 21 | 24% | 1.21 | 123 / 504 |
breast | 76% | 87.39 | 348 / 459 | 10% | 0.24 | 114 / 1118 |
prostate | 66% | 59.29 | 162 / 245 | 4% | 0.06 | 19 / 502 |
uterus | 62% | 54.52 | 105 / 170 | 7% | 0.50 | 30 / 459 |
lung | 42% | 36.67 | 242 / 578 | 14% | 0.32 | 157 / 1155 |
heart | 55% | 215.21 | 471 / 861 | 0% | 0 | 0 / 0 |
skin | 42% | 33.76 | 767 / 1809 | 11% | 0.21 | 52 / 472 |
peripheral blood | 43% | 73.40 | 396 / 929 | 0% | 0 | 0 / 0 |
adipose | 36% | 30.39 | 437 / 1204 | 0% | 0 | 0 / 0 |
spleen | 34% | 19.00 | 81 / 241 | 0% | 0 | 0 / 0 |
kidney | 17% | 9.02 | 15 / 89 | 8% | 0.13 | 69 / 901 |
thymus | 4% | 5.19 | 28 / 653 | 12% | 1.86 | 75 / 605 |
ovary | 8% | 4.65 | 14 / 180 | 1% | 0.03 | 3 / 430 |
adrenal gland | 0% | 0 | 0 / 258 | 7% | 0.39 | 17 / 230 |
eye | 0% | 0 | 0 / 0 | 4% | 0.05 | 3 / 80 |
blood vessel | 2% | 2.18 | 29 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0006935 | Biological process | chemotaxis |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0045745 | Biological process | positive regulation of G protein-coupled receptor signaling pathway |
GO_2000255 | Biological process | negative regulation of male germ cell proliferation |
GO_0005886 | Cellular component | plasma membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0004958 | Molecular function | prostaglandin F receptor activity |
GO_0042923 | Molecular function | neuropeptide binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0004956 | Molecular function | prostaglandin D receptor activity |
GO_0001785 | Molecular function | prostaglandin J receptor activity |
Gene name | PTGDR2 |
Protein name | Prostaglandin D2 receptor 2 (Chemoattractant receptor-homologous molecule expressed on Th2 cells) (G-protein coupled receptor 44) (CD antigen CD294) |
Synonyms | CRTH2 GPR44 DL1R |
Description | FUNCTION: Receptor for prostaglandin D2 (PGD2). Coupled to the G(i)-protein. Receptor activation may result in pertussis toxin-sensitive decreases in cAMP levels and Ca(2+) mobilization. PI3K signaling is also implicated in mediating PTGDR2 effects. PGD2 induced receptor internalization. CRTH2 internalization can be regulated by diverse kinases such as, PKC, PKA, GRK2, GPRK5/GRK5 and GRK6. Receptor activation is responsible, at least in part, in immune regulation and allergic/inflammation responses. . |
Accessions | ENST00000332539.5 Q9Y5Y4 |